At this time of year my phone starts to ring with enquiries from people suffering from hay fever and allergies.  I remember one patient in her twenties Nikki, who had suffered with chronic and debilitating hay fever symptoms since primary school.  Conventional treatment hadn’t helped and she was highly irritable and severely itchy.  ‘I’ve gone through every antihistamine on the market!’ she told me at her first consultation.

Within 2 months of starting her homeopathic treatment with me, she reported she was able to stop taking her antihistamine on a regular basis and her symptoms were abating. A month later she gave it up altogether.  Her gardener fiancé was very pleased as she was able to help him pot up the hanging baskets he sold!

She had always wanted to ride horses but had been unable to do this as a child because of her allergic reaction to them.  Two years after her initial consultation she contacted me to say that she had taken up horse riding and was suffering again.  On this occasion her symptoms pointed to a different homeopathic medicine, one that addressed her inherited allergic predisposition.  She continues to ride horses and the family has even been able to have a cat.

Nikki is not alone in seeking a natural and safe solution to her hay fever.  And a number of clinical trial findings have been positive for homeopathy and are listed below.[1]–[2]

Nikki says ‘homeopathy changed my life. I am finally able to do all the things I love doing, gardening and horse riding without worrying about them making me feel so unwell. I can’t recommend it enough’.

 

[1] Taylor MA, Reilly D, Llewelyn-Jones RH, et al. Randomised controlled trials of homeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. British Medical Journal 2000; 321: 471-6

[2]KIm LS, Rieflinger JE, Baldwin CM, Hilli L, Khalsa SV, Messer SA, Waters RF.  Treatment of seasonal allergic rhinitis using homeopathic preparation of common allergens in the southwest region of the US: a randomised, controlled clinical trial. Annals of Pharmacotherapy 2005; 39 (4): 617-24